Skip to content

The learning curve of diagnosis of colorectal lesions with endocytoscopes: a prospective study

The learning curve of diagnosis of colorectal lesions with endocytoscopes: a prospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300070225
Enrollment
Unknown
Registered
2023-04-06
Start date
2023-04-06
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early colorectal carcinoma

Interventions

Gold Standard:pathology
Index test:The accuracy of endoscopists diagnosing early colorectal cancer with endocytoscopes.

Sponsors

Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Endoscopists: (1) Endoscopists from our department; (2) Specilizing in ordinary colonoscopy, magnifying endoscopy + NBI with >=100 cases; 2. Patients: (1) Age >=18 years; (2) Suitable for endoscopic technology and treatment; (3) Current patients with colorectal lesions confirmed by white light endoscopy and/or narrow-bind imaging; (4) Patients undergoing colonoscopy or follow-up of colonic lesions; (5) Patients who are willing and able to provide written informed consent to participate in the study and to follow the study procedures; (6) Patients who are willing to accept examination requirements, such as consent to take biopsies for histopathological examination.

Exclusion criteria

Exclusion criteria: 1. Endoscopists: Endoscopists who withdrew from the study for personal reasons. 2. Patients: (1) After colorectal resection; (2) Colonic melanosis, sessile serrated lesions; (3) Patients taking anti-plate, anticoagulant drugs, or with abnormal coagulation function: INR > 1.5 and uncorrectable bleeding disease; Platelets < 50,000/mm3; (4) Pregnant patients; (5) Patients participating in another clinical trial that may affect the data collectors in this study; (6) Patients with vital organ dysfunction or severe cardio-cerebrovascular disease who cannot tolerate endoscopic treatment.

Design outcomes

Primary

MeasureTime frame
Accuracy;sensitivity;specificity;positive predictive value;negative predictive value;

Countries

China

Contacts

Public ContactPeng Li

Beijing Friendship Hospital, Capital Medical University

lipeng@ccmu.edu.cn+86 10 63139842

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026